The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD
Canadian Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1155/cjgh/5871321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2025. Verfasst von Haoxuan Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Body Mass Index, Triglycerides, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Background
Triglyceride glucose (TyG) and its related index (TyG‐body mass index, TyG‐BMI) are recognized as markers for nonalcoholic fatty liver disease (NAFLD), but their associations with metabolic dysfunction‐associated steatotic liver disease (MASLD) and significant liver fibrosis (SLF) risk are less studied. Therefore, this study explores the effectiveness of these indices in assessing MASLD and SLF risk in the U.S. population.
Methods
Utilizing data from the National Health and Nutrition Examination Survey (NHANES), a cross‐sectional study involving 5520 participants from the general population was performed. This research measured demographic, anthropometric, biochemical, comorbid, and lifestyle characteristics, all of which are considered risk factors for MASLD/SLF.
Results
Upon controlling for confounding variables, only the TyG‐BMI was found to have a consistent positive association with the risk of MASLD and SLF. Specifically, for each standard deviation increase, the odds ratio (OR) and 95% confidence interval (CI) were 4.44 (3.64–9.26, p for trend < 0.001) for MASLD and 2.48 (2.15–2.87, p for trend < 0.001) for SLF. Significant interactions were identified among age, sex, and the risk of MASLD associated with the TyG‐BMI. The TyG‐BMI also had a significant threshold effect on the risk of MASLD at a cutoff point of 180.71. Furthermore, the area under the receiver operating characteristic curve (AUC) revealed that the TyG‐BMI better predicted the risk of MASLD and SLF (AUC 0.820, 95% CI 0.810–0.831; AUC 0.729, 95% CI 0.703–0.756, respectively). In addition, the integrated discrimination improvement (IDI), decision curve analysis (DCA), and net reclassification index (NRI) also demonstrated the satisfactory predictive ability of the TyG‐BMI.
Conclusions
Within this large dataset, the TyG‐BMI was independently associated with both the MASLD score and the SLF in the MASLD cohort. Its predictive efficacy consistently surpassed that of TyG and other noninvasive models, indicating that TyG‐BMI has potential for the early identification of MASLD and SLF risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Haoxuan Zou, Jiejie Xie, Xiaopu Ma, Yan Xie
Förderung
- Sichuan Province Science and Technology Support Program
Zitieren
APA
Zou, H., Xie, J., Ma, X., & Xie, Y. (2025). The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/cjgh/5871321
Vancouver
Zou H, Xie J, Ma X, Xie Y. The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD. Canadian Journal of Gastroenterology and Hepatology. 2025. doi:10.1155/cjgh/5871321
BibTeX
@article{Zou2025,
author = {Zou, Haoxuan and Xie, Jiejie and Ma, Xiaopu and Xie, Yan},
title = {The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1155/cjgh/5871321}
}
EUVIMED